Medtech Acquisition Corp Stock Return On Asset
| MTACDelisted Stock | USD 10.55 0.03 0.28% |
MedTech Acquisition Corp fundamentals help investors to digest information that contributes to MedTech Acquisition's financial success or failures. It also enables traders to predict the movement of MedTech Stock. The fundamental analysis module provides a way to measure MedTech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedTech Acquisition stock.
MedTech |
MedTech Acquisition Corp Company Return On Asset Analysis
MedTech Acquisition's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MedTech Acquisition Return On Asset | -0.0193 |
Most of MedTech Acquisition's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MedTech Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, MedTech Acquisition Corp has a Return On Asset of -0.0193. This is 95.89% lower than that of the Capital Markets sector and significantly lower than that of the Financials industry. The return on asset for all United States stocks is 86.21% lower than that of the firm.
MedTech Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedTech Acquisition's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedTech Acquisition could also be used in its relative valuation, which is a method of valuing MedTech Acquisition by comparing valuation metrics of similar companies.MedTech Acquisition is currently under evaluation in return on asset category among its peers.
MedTech Fundamentals
| Return On Asset | -0.0193 | |||
| Current Valuation | 79.84 M | |||
| Shares Outstanding | 7.39 M | |||
| Shares Owned By Insiders | 84.51 % | |||
| Shares Owned By Institutions | 17.16 % | |||
| Number Of Shares Shorted | 2.85 K | |||
| Price To Earning | 31.28 X | |||
| Price To Book | 1.31 X | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Short Ratio | 1.00 X | |||
| Earnings Per Share | 0.05 X | |||
| Beta | -0.0423 | |||
| Market Capitalization | 83.86 M | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
| Working Capital | (2.14 M) | |||
| Z Score | 18.76 | |||
| Net Asset | 20.19 M |
About MedTech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedTech Acquisition Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedTech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedTech Acquisition Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |